Come and visit me at the Pacific Water Conference, booth 520! Anthony Pompliano Net Worth Phone Number, House Address, Wiki, Ashley Massengill Net Worth | Bio, Family, Address, Career, Atlas Monroe Net Worth | Age, Height, Weight, Dating And More, Beyonce S Net Worth Phone Number, House Address, Wiki, Blue Ivy Net Worth Phone Number, House Address, Wiki. NEW ORLEANS Esperion Therapeutics revealed long-awaited data on its heart pills efficacy in cutting severe cardiovascular outcomes, three years after the drug was cleared for use to lower cholesterol levels. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Social image: Peter Kolchinsky and Raj Shah, RA Capital Management, Digital therapeutics support increased access to safe and effective therapies, providing an untapped opportunity for biopharmaceutical companies to maximize the value of medicinal assets and drive differentiation Early Life Peter Kolchinsky was born in the United States of America. No. Peter is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools and serves on the boards of publicly- and privately-held life science companies. In the last year at Solid Biosciences Inc, Peter Kolchinsky has sold an estimated value of $0 worth. In addition, he makes $151,598 as Independent Director at Wave Life Sciences. Peter Kolchinsky, PhD '01, is a founder, Portfolio Manager, and Managing Director at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and life sciences. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. CB Rank (Investor) 53,342 Primary Job Title Portfolio Manager and Managing Director Primary Organization RA Capital Management Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male Investor Type Investment Partner LinkedIn View on LinkedIn Anna and Peter discovered Woodstock through Annas participation at the GMHA dressage events. You are looking for the virus through an RT-PCR test. Insider trading is most common in March, with the busiest year in 2015. The Voluntary Scheme for Branded Medicines Pricing and Access is the second option, and typically has lower rates and is negotiated between the government and pharmas. Peter served on the Board of Global Science and Technology for the National Academy of Sciences and writes about the biotech social contract. Thus, plans for a second home for two quickly gave way to a new dream and a substantial life-style change for four. 2001 - Present22 years. These two energetic couples are living their dream with energy, imagination, creativity and a whole lot of. Pathos AI is currently in the works and attempting to raise about $40 million, per an SEC filing from this week. The outspoken and occasionally caustic Kolchinsky is partnered with an urbane and widely-liked Shah. In the companys CLEAR study of nearly 14,000 patients, Esperions drug Nexletol cut the combined risk of heart attack, stroke, cardiovascular death or the need for coronary revascularization by 13%, compared with placebo. Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. Everyone has been so generous with us, sharing advice and stories. The URI to TrackBack this entry is: https://bluehorseinnvermont.wordpress.com/2010/03/14/the-blue-horse-six/trackback/. Above is the net worth, insider trading, and ownership report for Kolchinsky Peter. Peter Kolchinsky - Insider Trading Tracker . It was written by our very kind neighbor, Hasse K. Halley. But many people worry that Covid-19 will mutate and . Integrating digital therapeutics early in the asset development process will allow for gathering of clinical data to drive a clearer value proposition that maximizes the potential of both products The estimated net worth of Peter Kolchinsky is at least $1.2 Billion dollars as of 2023-02-17. The current estimated net worth of Mineralys Therapeutics, Inc's Director, Peter Kolchinsky, is estimated to be about $2.92B . So lets meet our newest neighbors in Woodstock. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. One of my favorite paintings is from the Blue Horses series by the German painter Franz Marc, Anna explained, and, of course, horses were what brought the couple to Woodstock in the first place. The fund was seeded by Vertex Pharma co-founder Rich Aldrich, who invested $4 million at . . One hopeful voice is biotech investor Peter Kolchinsky, the founder of RA Capital Management. The oldest executive at Wave Life Sciences Ltd. is KojiMiura, 71, who is the Independent Director. May 5, 2003 Like all mothers, Evelina Kolchinsky wanted her son, Peter, to adjust to school and do well. The co-heads of the venture at RA are Josh Resnick and Andrew Levin, working with 9 other professionals. But, as it often does, chance overrode plan, and they both fell in love with the property on the first visit. Words cant bring Christina Aguilera down but frown lines can. In this conversation. Peter's reported annual income is about $100 - 149,999; with a net worth that tops $50,000 - $99,999. Bens wife, Keri, grew up on a red dirt road in small-town Georgia. Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups John Carroll Editor & Founder Josh Resnick RA Capital Peter Kolchinsky and Raj Shah have another $300. Tweet With huge thanks to RA Capital's Alex Martinez-Forte and Jacqueline Rhuda for extensive data analysis. Berkshire Hathaway BRK.B +0.31% 's future leaders, including Greg Abel, will be expected to put many of their financial eggs in the conglomerate's basket. Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $38,029,167 and over the last 9 years he sold WVE stock worth over $58,095,632. The most active traders at the company are We'll e-mail you a link to set a new password. The current estimated net worth of Solid Biosciences Inc's Director, Peter Kolchinsky, is estimated to be about $2.7B . The Statutory Scheme, which is governed under UK law, is one of two that companies can use. Carl Ashley Morris who sold, In the last 5 years, insiders at Solid Biosciences Inc have sold an estimated value of, Mailing address is 200 Berkeley Street 18th Floor Boston MA 02116 MA. The higher rates are proposed to kick in on April 1. Dr. Kolchinksy's hedge fund held 9.7 million Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) shares by the end of Q3 of 2021. Peter Kolchinsky Oct 5, 2018 Direct-to-Consumer (DTC) advertising: misnamed, misunderstood, and underappreciated Maligned by doctors and often parodied, appropriately regulated. . Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Mineralys Therapeutics, Inc's most recent insider trade came on February 16, 2023 by , Keri said, adding that she hopes the new business still allows her some time for her own writing. Peter Kolchinsky's largest purchase order was 3,178,476 units , worth over Verified account Protected Tweets @ Protected Tweets @ The most recent stock trade was executed by Chandra Vargeese on 16 February 2023, trading 10,249 units of WVE stock currently worth $41,303. This investment adviser does not provide advice to individual investors. Covid-19. (LogOut/ Both Moffitt Cancer Center and Mayo Clinic in Florida, not too far from Domingos and his family, said he would have to wait between three and a half and four months to get the treatment. Baeder explains below not only whats coming for AAM and its member generic drug companies, but also her thoughts on the Inflation Reduction Act and the new five-year FDA user fee deal. Peter Kolchinsky graduated from Harvard with a Ph.D. in virology in 2001. Wave Life Sciences executives and other stock owners filed with the SEC include: Probieren Sie wallmine & ndash; es ist kostenlos. In total, Peter Kolchinsky has made about 5 transactions over a year of their time at Solid Biosciences Inc. She received her bachelors degree from Furman University in South Carolina in Philosophy and Asian Studies. Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $46,860,585 and over the last 8 years he sold WVE stock worth over $58,095,632. Wallmine is a radically better financial terminal. The companies RA Capital expects to build will range from single-assets to broad platforms, spanning early discovery through late clinical stage, across all therapeutic areas, such as neurology, rare disorders, oncology, and cardiovascular disease, said Levin in a prepared statement. Recently at Mineralys Therapeutics, Inc, Peter Kolchinsky has sold an estimated value of $0 worth. In addition, he makes $151,598 as Independent Director at Wave Life Sciences. Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. The Entrepreneur's Guide to a Biotech Startup. Currently GuruFocus does not have mailing address information for Kolchinsky Peter. one-time use only and expires after 24 hours. Warren Buffett has made it clear. Recently at Dyne Therapeutics, Inc, Peter Kolchinsky has sold an estimated value of $0 worth. The most active traders at the company are Fundamental company data provided by Morningstar, updated daily. He holds a BA from Cornell University and a PhD in Virology from Harvard University. Come and visit me at the Pacific Water Conference, booth 520! Dr. Kolchinsky also leads RA Capitals engagement and publishing efforts, which aim to make a positive social impact and spark collaboration among healthcare stakeholders, including patients, physicians, researchers, policymakers, and industry. $12.54M on September 23, 2020. foundation had somehow failed patients by allowing Vertex to price its drugs so high that a 10 percent royalty could be worth so much. Peter Kolchinsky owns about 1,311,247 units of Mineralys Therapeutics, Inc common stock. (LogOut/ S&P 500 Aggregate Buffett-Munger Screener Industry Overview Undervalued Predictable Benjamin Graham Net-Net 52-week/3Y/5Y Lows 52-week/3Y/5Y Highs Magic Formula (Greenblatt) . Keri is also a writer and is currently working on a Southern gothic novel. Dr. Kolchinsky is a founder and Managing Partner of RA Capital Management, L.P., a multi-stage investment manager which is dedicated to evidence-based investing in healthcare and life science companies that are developing drugs, medical devices, and diagnostics, where he has worked since 2001. I don't believe that temperature plays a role in the spread of Covid-19. Insider trading is most common in June, with the busiest year in 2022. The most active insiders traders include Capital Management, L.P.Ra , Capital Management, Llc Kol und Peter Kolchinsky. Peter Kolchinsky owns about 10,916,567 units of Solid Biosciences Inc common stock. Change), You are commenting using your Twitter account. He serves as a member of the board of directors of a number of private companies. Unlock this article along with other benefits by subscribing to one of our paid plans. He studied philosophy at Oregon State University and then, a law degree from the University of Oklahoma. More Peter Kolchinsky, Ph.D. To get here required a long and winding route. So they invited their close friends Keri and Ben up for what they expected to be a reality check. . A biotech analyst bets Novavax has the best data. Peter Kolchinsky. Most recently he bought 4,000,000 units of WVE stock worth $80,000,000 on 23 June 2020. During. Alfredo Naj Domingos prostate cancer was spreading. He currently manages a fund that invests in healthcare and biotechnology companies. Peter Kolchinsky, Ph.D., has more than 18 years of experience in healthcare investing and is the founder of and a managing partner at RA Capital. Hbm Healthcare Investments Cayman Ltd who bought 3,218,106 units worth Couple Number Two: Ben Ford and Keri Cole: Ben Ford was born and raised in Ames, Iowa. Generic drugs are more often than not the unsung heroes in healthcare, generating billions in savings every year and increasing access to vital new medicines as the brand-name versions come off patent. Health Care. Momentum Activist Targets Dividend Yield Microcap with Revenue NCAV Screen Net Net Working Capital Negative Enterprise Value Piotroski Score ROIC Screen Short Volume Ratio High . According to world-renowned virologist Peter Kolchinsky, the SARS-CoV-2 virus is nothing short of an "evil genius". As the Independent Director of Wave Life Sciences, the total compensation of Peter Kolchinsky at Wave Life Sciences is $151,598. UCLA CTSI | Accelerating Discoveries Toward Better Health | Main He co-founded and runs the Boston-based investment firm RA Capital Management, writes and teaches about biomedical entrepreneurship and its potential to transform global health, serves on the boards of several public and private drug development companies, and has served on the Board of Global Science and Technology for the National . In this conversation. document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() ); Blog at WordPress.com.RSS 2.0Comments RSS 2.0, The Blue Horse Inn (AKA) Number Three Church Street and (AKA) The Lauren has a new name and four new proprietors: Peter, Anna, Ben, and Keri. It will take some time, but rest assured: a coronavirus vaccine is coming, and it will work. Hbm Healthcare Investments Cayman Ltd who bought, In the years Mineralys Therapeutics, Inc was active, insiders at Mineralys Therapeutics, Inc have bought an estimated value of, Mailing address is 200 Berkeley Street 18th Floor Boston MA 02116 MA. This is where youll find the low down on whats happening in and around the BHI. out how to maintain the house themselves, from the roof to the, Anna and Keri hope their husbands dont electroc, can be found busily working at The Blue Horse Inn most weekends. Past performance is a poor indicator of future performance. The malignant cells permeated his bones, kidney, lungs and liver, and in December, his oncologist told him there was no point in continuing chemotherapy treatment. Forbes and business insiders have done a recent study and say that Peter Kolchinsky net worth is more than a couple of million dollars. In addition, he makes $151,598 as Independent Director at Wave Life Sciences. . Welcome to the official Blue Horse Inn blog! You can see the complete history of Peter Kolchinsky stock trades at the bottom of the page. All Rights Reserved. The drug industry stands accused of charging too much. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. In addition to The Great American Drug Deal, he is the author of The Entrepreneurs Guide to a Biotech Startup. Peter Kolchinsky is Chairman/CEO at Research Alliance Corp II. Required fields are marked *. Harvard Divinity School and began doctoral work in Buddhist studies at the University of California, Berkeley. Peter is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research . (LogOut/ Most importantly, this book describes concrete, actionable reforms under which patients will be able to afford their treatments and society will continue to reap the benefits of medical innovation. It was simply awesome! Source: https://www.sec.gov/Archives/edgar/data/1818794/000119312521116286/d937458ddef14a.htm. Your email address will not be published. . He is active in both public and private investments in companies developing drugs, medical devices, diagnostics and research tools and serves as a board member for various public and privately-held . "And another thread that speaks to need for insurance reform. I am on Oahu until Friday, so please feel free to also contact me directly in order to discuss Unlock this story instantly and join 161,900+ biopharma pros reading Endpoints daily and it's free. . Peter Kolchinsky owns about 2,805,045 units of Dyne Therapeutics, Inc. A hike is also under consideration for the voluntary scheme. Dyne Therapeutics, Inc's most recent insider trade came on January 23, 2023 by The biopharmaceutical industry will be able to make a Covid-19 vaccineprobably a few of themusing various existing vaccine technologies. Save my name, email, and website in this browser for the next time I comment. Shes currently earning her PhD in European History at Boston. Gurus may be added or dropped from the GuruFocus site at any time. This ground-breaking new book, The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines (January 20, 2020), by Peter Kolchinsky, PhD, examines the healthcare landscape through the lens of the biotech social contract with America - the implicit agreement between the biopharmaceutical industry and American society - including the government's role in inventing . She received her bachelors degree from Furman University in South Carolina in Philosophy and Asian Studies. They fell in love with the historic character and natural beauty of the area and, as they met more of the towns residents, realized that Woodstock was a community that they would like to be part of. Peter Kolchinsky started RA Capital Management after completing his Ph.D. in virology from Harvard in 2001. Jonathan McNeill who sold, In the last 16 years, insiders at Dyne Therapeutics, Inc have sold an estimated value of, https://www.sec.gov/Archives/edgar/data/1818794/000119312521116286/d937458ddef14a.htm, Mailing address is 200 Berkeley Street 18th Floor Boston MA 02116 MA. In the interim, they plan to invite, Were not in a rush, Anna explained, and want to take some time to get to know the. Other family members and associates include Alexander Kolchinsky, Evelina Kolchinsky, Anna Kolchinsky, Joseph Kolchinsky and Joseph Kolchinsky. At least three dozen biotechs let employees go so far this year, based on Endpoints News reporting, with more having done so under the radar. Ignoring warning calls from pharma companies and the Association of the British Pharmaceutical Industry (ABPI), the UK government announced its planning to raise the revenue clawback rate paid by pharmaceutical companies on the Statutory Scheme for Branded Medicines from 24.4% to 27.5%. RA Capital Management, L.P. is the investment manager of RA Capital Healthcare Fund, L.P. I am on Oahu until Friday, so please feel free to also contact me directly in order to discuss Change). The current estimated net worth of Solid Biosciences Inc's Director, Peter Kolchinsky, is estimated to be about $2.89B . In total, Peter Kolchinsky has made about 1 transaction recently at Dyne Therapeutics, Inc. The Great American Drug Deal was released on January 20, 2020. . Many proposed solutions, including drug price controls, threaten to defund innovation but also distract the public from the real problem, which lies in the unraveling of the biotech social contract the implicit agreement between the biopharmaceutical industry and American society. Anna is excited about introducing her dressage horse Jurist to the local network of trails. Please note this link is one-time use only and is valid for only 24 hours. Before moving to Anna's current city of Boston, MA, Anna lived in Woodstock VT and Carlisle MA. On average, Rajeev trades about 455,121 units every 31 days since 2016. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. This new fund of theirs arrives well into a go-go era of new startup financing, with a particular focus on building new biotechs. Kolchinsky who spoke to senior editor Shiv Aroor as part . How do you see re-infections? As for Peter, As soon as we get the house in order, Im looking forward to some fishing. When developed in combination with a medicinal asset, digital therapeutics enable significant market differentiation and significant benefits for stakeholdersfrom optimizing patient outcomes to supporting more efficient generation of compelling real-world data Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. The foursome plans to open for guests in the late spring of 2010. The current estimated net worth of Mineralys Therapeutics, Inc's Director, Peter Kolchinsky, is estimated to be about $2.7B . She received a Masters degree in TV production at Boston University and worked in film production in Berlin for several years before returning to Boston, where she met Peter. Carl Ashley Morris who sold 441 units worth Its a longstanding agreement between the government and industry to keep medicines affordable for the National Health Service (NHS). Merz has previously enlisted singer-songwriters Joe Jonas and Teyana Taylor, 33 and 31 years old respectively, who tout the anti-wrinkle injection as a solution for frown lines without any unnecessary ingredients., Bioscience & Technology Business CenterThe University of KansasLawrence, Kansas. "Stay tuned for more covid and science explainers. Peter has made over 5 trades of the Wave Life Sciences stock since 2018, according to the Form 4 filled with the SEC. . Adam Levy, CFO, Peter Kolchinsky is the Director, 10% Owner of Synthorx Inc and owns about 14,903,741 shares of Synthorx Inc (THOR) stock worth over $1.0 Billion . In the years Mineralys Therapeutics, Inc was active, insiders at Mineralys Therapeutics, Inc have bought an estimated value of $0 worth of shares. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The real solution to affordability is hidden in plain sight amidst all the rhetoric about drug prices. Kolchinsky's new book, The Great American Drug Deal: A New Prescription for Innovative and. Past performance is a poor indicator of future performance. $5M . The largest trade he's ever made was buying 4,545,455 units of Wave Life Sciences stock on 11 December 2018 worth over $50,000,005. Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Refer a Friend and Earn One Month of Free Membership. America is rightfully outraged when patients cant afford the medicines they need. Dr. Peter Kolchinsky Ph.D. serves as Independent Director of the Company. In the interim, they plan to invite local folks in to see the changes, try out some wines, and make new friends. This investment adviser does not provide advice to individual investors. Peter Kolchinsky and Raj Shah have another $300 million-plus to play with on the biotech venture side of their investment business. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. the community will feel welcome. Hedge Fund Net Worth $4.93B Peter Kolchinsky manages more assets than 43% of other Hedge Fund Managers Average Return +0.32% Since Last Filing Last 12 Months 3 Years (Annualized) Portfolio Breakdown by Sector Portfolio Breakdown 97.31% Healthcare 1.12% Services 0.78% Technology 0.51% Financial RA Capital Management Portfolio Activity Company Name Gurus may be added or dropped from the GuruFocus site at any time. Ilan Ganot, Director, The RA Capital Nexus Fund closed at just over $300 million, they said in a statement. The campaign launched last year, targeting people in their 20s and 30s, Merz Aesthetics North America president Patrick Urban told Endpoints News at the time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. GuruFocus.com is not operated by a broker or a dealer. https://t.co/y9IG2Z5txl" He served on the Board of Global Science and Technology for the National Academy of Sciences from 2009 to 2012, is the author of "The Great American Drug Deal" and "The Entrepreneurs Guide to a Biotech Startup", and frequently writes and speaks on the future of biotechnology innovation. January 3, 2023 Feb 10th, Ed. Stock quotes provided by InterActive Data. All Rights Reserved. October 20, 2021The vaccine business has long been a quiet and profitable game of kings. Opinion. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. $12.69M on March 23, 2021. Jonathan McNeill who sold 10,000 units worth and bought an estimated value of $190.71M worth of shares. These things have helped him get to where he is now one of the richest people on Earth. Downloadable as a .pptx file. There are also venture partner and executive-in-residence programs to build up the bench. Franklin Resources Inc, Peter Kolchinsky. As for their long-term goals, Peter and Ben are determined to figure out how to maintain the house themselves, from the roof to the plumbing, by the time they retire. Wishing you all the best of luck in your new endeavor. Your email address will not be published. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. Peter Kolchinsky owns about 2,805,045 units of Dyne Therapeutics, Inc common stock. Boston, MA. These . Sign up here. After serving in the US Air Force JAG Corps, Ben worked at a private law firm and in Massachusetts state government. After serving in the US Air Force JAG Corps, Ben, at a private law firm and in Massachusetts, He currently works with the State and Local Government Practice Group of. Dr. Kolchinsky's RA Capital held 9 million Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) shares worth $208.9 million which represented 2.89% of its portfolio during Q3. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Peter Kolchinsky: It has infected people in different parts of the world. March 31, 2020. In addition, he makes $151,598 as Independent Director at Wave Life Sciences. Peter's wife, Anna, grew up in Germany, Austria, and France, and came to Bost on to attend Wellesley College. In . Prevnar, a shot that prevents pneumococcal infections, is a Pfizer blockbuster. The estimated Net Worth of Peter Kolchinsky is at least $96.3 Million dollars as of 23 June 2020. Currently GuruFocus does not have mailing address information for Kolchinsky Peter. Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $37,758,818 and over the last 9 years he sold WVE stock worth over $58,095,632. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Anna is ex, cited about introducing her dressage horse, Im looking forward to some fishing. He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and Peter, Anna, Ben and Keri can be found busily working at The Blue Horse Inn most weekends, often with friends and family, and invite the neighbors to stop in and say hello. There are 12 executives at Wave Life Sciences getting paid more, with PaulBolno having the highest compensation of $3,581,530. See Peter Kolchinsky's compensation, career history, education, & memberships. Anna Kolchinsky was born on 03/30/1979 and is 43 years old. Well be posting shots of the different projects around the inn in the coming weeks, but first we thought you might like to know a little bit about us. Lefkofsky co-founded Groupon, is a trustee of many marquee Chicago institutions and co-manages the Midwest VC firm Lightbank, which is currently looking to raise $250 million for its third fund, per another document filed with the SEC last November. The current estimated net worth of Dyne Therapeutics, Inc's Peter Kolchinsky is estimated to be about $2.7B . Change), You are commenting using your Facebook account. The largest trade he's ever made was buying 6,337,135 units of Kala Pharmaceuticals Inc stock on 13 March 2020 worth over $49,999,995. Dr. Kolchinsky's firm held 7.3 million Ascendis Pharma A/S (NASDAQ:ASND) shares in Q3, which were worth $1.17 billion and made up for 16.31% of its portfolio. Stock quotes provided by InterActive Data. Industry is going to have to give "a pound of flesh," Kolchinsky argued, and he's explicit on the business practices biopharma must abandon to get a fair system that still rewards innovation. Things here have been busy; were working hard to get the inn ready for our June 2010 grand opening. More than 100 drug developers thinned their organization charts last year. Hard work has helped him rise to the top. and bought an estimated value of $64.19M worth of shares. Peter Kolchinsky usually trades in February, with the busiest year in 2023. The most active traders at the company are